For: | Kim SO, Han SY, Baek YH, Lee SW, Han JS, Kim BG, Cho JH, Nam KJ. Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient. World J Gastroenterol 2011; 17(2): 267-270 [PMID: 21246003 DOI: 10.3748/wjg.v17.i2.267] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i2/267.htm |
Number | Citing Articles |
1 |
Constantin A Dasanu, Premkumar Padmanabhan, Bernard A. Clark, Christine Do. Cardiovascular toxicity associated with small molecule tyrosine kinase inhibitors currently in clinical use. Expert Opinion on Drug Safety 2012; 11(3): 445 doi: 10.1517/14740338.2012.672971
|
2 |
Chieh-Ching Yen, Chih-Kai Wang, Shou-Yen Chen, Shi-Ying Gao, Hsiang-Yun Lo, Chip-Jin Ng, Chung-Hsien Chaou. Risk assessment and prognostic analysis of patients with splenic infarction in emergency department: a multicenter retrospective study. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-00897-0
|
3 |
Nicholas A. Barber, Wais Afzal, Mojtaba Akhtari. Hematologic toxicities of small molecule tyrosine kinase inhibitors. Targeted Oncology 2011; 6(4): 203 doi: 10.1007/s11523-011-0202-9
|
4 |
Yosuke Aihara, Hitoshi Yoshiji, Masaharu Yamazaki, Yasuhide Ikenaka, Ryuichi Noguchi, Chie Morioka, Kosuke Kaji, Haruki Tastumi, Keisuke Nakanishi, Maiko Nakamura, Junichi Yamao, Masahisa Toyohara, Akira Mitoro, Masayoshi Sawai, Motoyuki Yoshida, Masao Fujimoto, Masahito Uemura, Hiroshi Fukui. A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2012; 4(5): 115-118 doi: 10.4251/wjgo.v4.i5.115
|
5 |
Chitra Viswanathan, Mylene Truong, Tara Sagebiel, Naveen Garg, Priya Bhosale. Imaging of Chemotherapy-related Iatrogenic Abdominal and Pelvic Conditions. Radiologic Clinics of North America 2014; 52(5): 1029 doi: 10.1016/j.rcl.2014.05.008
|
6 |
Chitra Viswanathan. Imaging of Complications and Toxicity following Tumor Therapy. Medical Radiology 2014; : 277 doi: 10.1007/174_2014_1049
|